Pesquisas alternativas:
new clamp » new camp (Expandir a Pesquisa), new claims (Expandir a Pesquisa), new class (Expandir a Pesquisa)
et comme » et comment (Expandir a Pesquisa)
worm dan » storm dan (Expandir a Pesquisa), worm a (Expandir a Pesquisa), worm lab (Expandir a Pesquisa)
dan non » than non (Expandir a Pesquisa), dan ning (Expandir a Pesquisa)
et com » et comb (Expandir a Pesquisa), et comp (Expandir a Pesquisa), et col (Expandir a Pesquisa)
e worm » _ worm (Expandir a Pesquisa), a worm (Expandir a Pesquisa), e work (Expandir a Pesquisa)
2 new » a new (Expandir a Pesquisa), 2 neu (Expandir a Pesquisa)
new clamp » new camp (Expandir a Pesquisa), new claims (Expandir a Pesquisa), new class (Expandir a Pesquisa)
et comme » et comment (Expandir a Pesquisa)
worm dan » storm dan (Expandir a Pesquisa), worm a (Expandir a Pesquisa), worm lab (Expandir a Pesquisa)
dan non » than non (Expandir a Pesquisa), dan ning (Expandir a Pesquisa)
et com » et comb (Expandir a Pesquisa), et comp (Expandir a Pesquisa), et col (Expandir a Pesquisa)
e worm » _ worm (Expandir a Pesquisa), a worm (Expandir a Pesquisa), e work (Expandir a Pesquisa)
2 new » a new (Expandir a Pesquisa), 2 neu (Expandir a Pesquisa)
1
2
Por Iosifescu, Dan V, Neborsky, Robert J, Valuck, Robert J
Publicado no Neuropsychiatr Dis Treat (2016)
“... of an ongoing, 2-year prospective, randomized, double blind, controlled study to evaluate PEER Interactive...”Publicado no Neuropsychiatr Dis Treat (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Friesen, Kevin J, Falk, Jamie, Alessi-Severini, Silvia, Chateau, Dan, Bugden, Shawn
Publicado no J Pain Res (2016)
“... person-years in 2013/14. PHN occurred in 9.2% of HZ cases, a rate that did not change over the study...”Publicado no J Pain Res (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Friesen, Kevin J, Alessi-Severini, Silvia, Chateau, Dan, Falk, Jamie, Bugden, Shawn
Publicado no Clinicoecon Outcomes Res (2016)
“... between 1997 and 2013. Of these episodes, 42,270 (57.2%) were treated with antiviral medications at a...”Publicado no Clinicoecon Outcomes Res (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
“.... CONCLUSION: Our study not only provides a new material for personalized treatment of tumors, but also further...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Oliver J. Harrison, Julia Brasch, Phinikoula S. Katsamba, Goran Ahlsen, Alex J. Noble, Hanbin Dan, Rosemary V. Sampogna, Clinton S. Potter, Bridget Carragher, Barry Honig, Lawrence Shapiro
Publicado em 2020-02-01
“...Summary: Non-clustered δ1- and δ2-protocadherins, close relatives of clustered protocadherins...”Publicado em 2020-02-01
Obter o texto integral
Artigo
7
Por Zeng, Zheng, Yang, Dan, Huang, Xiaoling, Xiao, Zhenliang
Publicado no Int J Chron Obstruct Pulmon Dis (2017)
“... studies that were published as protocol or written in non-English language (Number 42016047078). FINDINGS...”Publicado no Int J Chron Obstruct Pulmon Dis (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Yang, Hong-ye, Niu, Li-na, Sun, Jin-long, Huang, Xue-qing, Pei, Dan-dan, Huang, Cui, Tay, Franklin R
Publicado no Int J Nanomedicine (2017)
“... doses of recombinant bone-morphogenetic protein-2 in bone surgery, it is desirable to develop...”Publicado no Int J Nanomedicine (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
10
Por Song, Siyang, Fu, Hongzhe, He, Bing, Wang, Dan, Qin, Mengmeng, Yang, Dan, Liu, Dechun, Song, Ge, Shi, Yujie, Zhang, Hua, Wang, Xueqing, Dai, Wenbing, Zhang, Qiang
Publicado no Int J Nanomedicine (2018)
“...) and formulated their aqueous dispersion. A549 and Caco-2 cells were selected as the models of tumor...”Publicado no Int J Nanomedicine (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Zhang, DanDan, Kong, Yan Yan, Sun, Jia Hui, Huo, Shao Jie, Zhou, Min, Gui, Yi Ling, Mu, Xu, Chen, Huan, Yu, Shu Qin, Xu, Qian
Publicado no Int J Nanomedicine (2017)
“... S-D1@L-D2 NPs, where denoted some smaller nanoparticles (NPs) carrying a drug doxorubicin (DOX) were...”Publicado no Int J Nanomedicine (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Electrospun silk fibroin/poly(lactide-co-ε-caprolactone) nanofibrous scaffolds for bone regeneration
Por Wang, Zi, Lin, Ming, Xie, Qing, Sun, Hao, Huang, Yazhuo, Zhang, DanDan, Yu, Zhang, Bi, Xiaoping, Chen, Junzhao, Wang, Jing, Shi, Wodong, Gu, Ping, Fan, Xianqun
Publicado no Int J Nanomedicine (2016)
“... trabecular number, enhanced bone mineral density, and increased new bone areas, compared with the pure PLCL...”Publicado no Int J Nanomedicine (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Xue, Baiji, He, Dan, Gao, Song, Wang, Dongyang, Yokoyama, Koji, Wang, Li
Publicado no Int J Nanomedicine (2016)
“... in nature with an average diameter of 15.5±2.5 nm. Numerous factors could potentially affect the process...”Publicado no Int J Nanomedicine (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Zhou, Yi, Wang, Ruju, Chen, Bing, Sun, Dan, Hu, Yong, Xu, Peipei
Publicado no Int J Nanomedicine (2016)
“... NPs were evaluated, and their cytotoxicity was explored by 3-[4,5-dimethylthiazol-2-y1]-2...”Publicado no Int J Nanomedicine (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Liang, Aihui, Li, Chongning, Li, Dan, Luo, Yanghe, Wen, Guiqing, Jiang, Zhiliang
Publicado no Int J Nanomedicine (2017)
“..., with a detection limit of 70 pg/mL. Accordingly, two new GONR catalytic RRS/Abs methods were established...”Publicado no Int J Nanomedicine (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Zhu, Lianhua, Wang, Luofu, Liu, Yu, Xu, Dan, Fang, Kejing, Guo, Yanli
Publicado no Int J Nanomedicine (2018)
“.... USMI of targeted and non-targeted nanobubbles was performed in tumor-bearing nude mice...”Publicado no Int J Nanomedicine (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Hollis, Sally, Jorup, Carin, Lythgoe, Dan, Martensson, Gunnar, Regnell, Pontus, Eckerwall, Göran
Publicado no Int J Chron Obstruct Pulmon Dis (2017)
“... budesonide-containing versus non-budesonide-containing treatments and the impact of other clinically relevant...”Publicado no Int J Chron Obstruct Pulmon Dis (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
“..., the difference between the two groups was not significant (710.9 ± 312.8 vs. 850.9 ± 292.0 µg; P=0.078...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Mulder, Nicola, Abimiku, Alash’le, Adebamowo, Sally N, de Vries, Jantina, Matimba, Alice, Olowoyo, Paul, Ramsay, Michele, Skelton, Michelle, Stein, Dan J
Publicado no Pharmgenomics Pers Med (2018)
“... was established to drive new research into the genetic and environmental basis for human diseases of relevance...”Publicado no Pharmgenomics Pers Med (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Du, Wei, Liu, Jun, Zhou, Jianlong, Ye, Dan, OuYang, Yan, Deng, Qingnan
Publicado no Int J Chron Obstruct Pulmon Dis (2018)
“... who did not have OSA or COPD (adjusted hazard ratio [HR] =1.5 for the COPD group and 2...”Publicado no Int J Chron Obstruct Pulmon Dis (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo